Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236145
Status:
COMPLETED
Last Update Posted:
2013-01-29
First Post:
2005-10-07
Brief Title:
Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
C8278A302ONMN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cephalon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None